Market Cap

Relief Therapeutics Holding AG Market Capitalization:

CHF22.5 Million

CHF as of Jan. 1, 2024

US$26.8 Million

business Relief Therapeutics Holding AG Company Profile

Relief Therapeutics Holding AG Main Stock Listing

SIX: RLF

Market Capitalization History of Relief Therapeutics Holding AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Relief Therapeutics Holding AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 CHF22.5 M -83.56%
Jan. 1, 2023 CHF137.1 M -54.33%
Jan. 1, 2022 CHF300.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Relief Therapeutics Holding AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

Relief Therapeutics Holding AG has the following listings and related stock indices.


Stock: SIX: RLF

Stock: OTC: RLFTF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.